
We are so happy to start the new year and welcome new fellows, celebrate graduates, and see the transition from first year to second year. #NephFellow

Duke Division of Nephrology. Home to the Duke Nephrology Fellowship. #NephForward #LearnLiveLead Tweets by @Nephro_Sparks @nc_kuhtrio

We are so happy to start the new year and welcome new fellows, celebrate graduates, and see the transition from first year to second year. #NephFellow

New from #NephFaculty Dr Edmonston and Dr Catanese in JASN Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy: A Scoping Review pubmed.ncbi.nlm.nih.gov/4301…

New from Dr Musah in STAR protocols Protocol for the development and transcriptomic analysis of multiple human kidney disease models pubmed.ncbi.nlm.nih.gov/4297…

New from #NephFellow Dr DeMis and colleagues in JACC Case Reports Right Atrial Cardiac Fibroma Mimicking Eustachian Valve Endocarditis in Neutropenic Sepsis: A Diagnostic Challenge pubmed.ncbi.nlm.nih.gov/4296…


Sunday Read💫: A novel axis that can fine-tune the immune response to glomerular and tubule cell damage: doi.org/10.1172/jci.insight.… Jamie R. Privratsky @JamiePrivratsky & team @DukeKidney @Duke_Anesthesia identify a novel myeloid cell-endothelial cell immunoregulatory axis, supporting a model whereby myeloid IL-1R1 activity constrains ER stress–mediated EBI3/IL27 secretion, thereby attenuating type I IFN expression in kidney endothelial cells and ameliorating autoimmune nephritis. The figure shows anti-IFNAR1 therapy abrogates kidney injury after NTS nephritis in mice lacking IL-1R1 specifically in myeloid cells (bottom); littermate controls (top). #AKI #Nephrology #kidney #macrophage


Congrats to #NephFaculty Dr Sparks who will give the Burton D. Rose, MD, Endowed Lectureship at ASN Kidney Week 2026 in Denver CO, Oct 22nd “Formulating a Dialysis Access Curriculum: Bridging the Gap in Education and Training” kidneynews.org/view/journals…

Presenting a novel axis that can fine-tune the immune response to glomerular and tubule cell damage: Jamie R. Privratsky @JamiePrivratsky & team @DukeKidney @Duke_Anesthesia identify a novel myeloid cell-endothelial cell immunoregulatory axis, supporting a model whereby myeloid IL-1R1 activity constrains ER stress–mediated EBI3/IL27 secretion, thereby attenuating type I IFN expression in kidney endothelial cells and ameliorating autoimmune nephritis. The figure shows anti-IFNAR1 therapy abrogates kidney injury after NTS nephritis in mice lacking IL-1R1 specifically in myeloid cells (bottom); littermate controls (top). #AKI #Nephrology #kidney #macrophage

#NephFaculty Dr Steve Crowley chairs the AHA #Hypertension26 meeting in Arlington, VA professional.heart.org/en/me…

#FellowLife 1st year: Dr. Ethan Witt Residency: Oregon Health & Science University Med School: University of Vermont medicine.duke.edu/profile/et…

#FellowLife 2nd year: Dr. Mike Tabet Residency: University of Vermont Med School: Louisiana State University in New Orleans medicine.duke.edu/profile/mi…

New from #NephFaculty Dr Ortiz-Melo and Dr Coffman in JCI Insight Proximal tubule ACE2 mediates early responses to hypertension by regulating intrarenal RAS and sodium homeostasis insight.jci.org/articles/vie…

New form #NephFaculty Dr Rasheeda Hall and colleagues in Nature Reviews Nephrology Recommendations for the management of frailty in chronic kidney disease: a consensus report pubmed.ncbi.nlm.nih.gov/4279…

#FellowLife 1st year: Dr. Josh Daum Residency (chief resident): Mayo Clinic – Rochester, MN Med School: Mayo Clinic Alix School of Medicine – Phoenix, AZ medicine.duke.edu/profile/jo…

#FellowLife 1st year: Dr. Mason Kalada Residency: Wake Forest Med School: East Tennessee State University medicine.duke.edu/profile/ma…